|Bid||199.27 x 800|
|Ask||202.60 x 800|
|Day's Range||201.59 - 203.73|
|52 Week Range||141.32 - 210.00|
|Beta (5Y Monthly)||0.85|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2021|
|Forward Dividend & Yield||1.88 (0.93%)|
|Ex-Dividend Date||Aug 31, 2021|
|1y Target Est||240.31|
Subscribe to Yahoo Finance Plus to view Fair Value for MCKLearn more
Hill-Rom's (HRC) newly initiated long-term growth strategies through fiscal 2022, focusing on all four strategic priorities, look attractive at this moment.
Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.
Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.